| UniProt ID | RL10A_HUMAN | |
|---|---|---|
| UniProt AC | P62906 | |
| Protein Name | 60S ribosomal protein L10a | |
| Gene Name | RPL10A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 217 | |
| Subcellular Localization | ||
| Protein Description | Component of the large ribosomal subunit.. | |
| Protein Sequence | MSSKVSRDTLYEAVREVLHGNQRKRRKFLETVELQISLKNYDPQKDKRFSGTVRLKSTPRPKFSVCVLGDQQHCDEAKAVDIPHMDIEALKKLNKNKKLVKKLAKKYDAFLASESLIKQIPRILGPGLNKAGKFPSLLTHNENMVAKVDEVKSTIKFQMKKVLCLAVAVGHVKMTDDELVYNIHLAVNFLVSLLKKNWQNVRALYIKSTMGKPQRLY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSSKVSRDT ------CCCCCCHHH | 38.58 | 25072903 | |
| 2 | Acetylation | ------MSSKVSRDT ------CCCCCCHHH | 38.58 | 12962325 | |
| 3 | Phosphorylation | -----MSSKVSRDTL -----CCCCCCHHHH | 35.46 | 25072903 | |
| 4 | Sumoylation | ----MSSKVSRDTLY ----CCCCCCHHHHH | 36.60 | - | |
| 6 | Phosphorylation | --MSSKVSRDTLYEA --CCCCCCHHHHHHH | 28.33 | 28152594 | |
| 9 | Phosphorylation | SSKVSRDTLYEAVRE CCCCCHHHHHHHHHH | 30.08 | 28152594 | |
| 11 | Phosphorylation | KVSRDTLYEAVREVL CCCHHHHHHHHHHHH | 12.16 | 27273156 | |
| 23 | Methylation | EVLHGNQRKRRKFLE HHHHCCHHHHHHHHH | 38.15 | 115491583 | |
| 31 | Phosphorylation | KRRKFLETVELQISL HHHHHHHHEEEEEEC | 22.79 | 25690035 | |
| 37 | Phosphorylation | ETVELQISLKNYDPQ HHEEEEEECCCCCCC | 21.96 | 25690035 | |
| 45 | 2-Hydroxyisobutyrylation | LKNYDPQKDKRFSGT CCCCCCCCCCCCCEE | 71.28 | - | |
| 47 | Acetylation | NYDPQKDKRFSGTVR CCCCCCCCCCCEEEE | 63.48 | 25953088 | |
| 50 | Phosphorylation | PQKDKRFSGTVRLKS CCCCCCCCEEEEECC | 37.27 | 29214152 | |
| 52 | Phosphorylation | KDKRFSGTVRLKSTP CCCCCCEEEEECCCC | 10.97 | 21857030 | |
| 56 | Ubiquitination | FSGTVRLKSTPRPKF CCEEEEECCCCCCCE | 41.54 | - | |
| 62 | Acetylation | LKSTPRPKFSVCVLG ECCCCCCCEEEEEEE | 52.10 | 25825284 | |
| 62 | 2-Hydroxyisobutyrylation | LKSTPRPKFSVCVLG ECCCCCCCEEEEEEE | 52.10 | - | |
| 62 | Ubiquitination | LKSTPRPKFSVCVLG ECCCCCCCEEEEEEE | 52.10 | - | |
| 64 | Phosphorylation | STPRPKFSVCVLGDQ CCCCCCEEEEEEECH | 22.26 | - | |
| 66 | S-palmitoylation | PRPKFSVCVLGDQQH CCCCEEEEEEECHHH | 1.71 | 21044946 | |
| 74 | S-palmitoylation | VLGDQQHCDEAKAVD EEECHHHCCCCHHCC | 4.37 | 21044946 | |
| 74 | Glutathionylation | VLGDQQHCDEAKAVD EEECHHHCCCCHHCC | 4.37 | 22555962 | |
| 78 | 2-Hydroxyisobutyrylation | QQHCDEAKAVDIPHM HHHCCCCHHCCCCCC | 47.06 | - | |
| 78 | Acetylation | QQHCDEAKAVDIPHM HHHCCCCHHCCCCCC | 47.06 | 25953088 | |
| 78 | Ubiquitination | QQHCDEAKAVDIPHM HHHCCCCHHCCCCCC | 47.06 | - | |
| 85 | Sulfoxidation | KAVDIPHMDIEALKK HHCCCCCCCHHHHHH | 4.69 | 30846556 | |
| 91 | Acetylation | HMDIEALKKLNKNKK CCCHHHHHHHHHCHH | 63.36 | 23954790 | |
| 91 | 2-Hydroxyisobutyrylation | HMDIEALKKLNKNKK CCCHHHHHHHHHCHH | 63.36 | - | |
| 91 | Ubiquitination | HMDIEALKKLNKNKK CCCHHHHHHHHHCHH | 63.36 | 21890473 | |
| 91 | Malonylation | HMDIEALKKLNKNKK CCCHHHHHHHHHCHH | 63.36 | 26320211 | |
| 92 | Ubiquitination | MDIEALKKLNKNKKL CCHHHHHHHHHCHHH | 59.13 | - | |
| 92 | Acetylation | MDIEALKKLNKNKKL CCHHHHHHHHHCHHH | 59.13 | 156251 | |
| 106 | Sumoylation | LVKKLAKKYDAFLAS HHHHHHHHHHHHHHC | 42.63 | - | |
| 106 | Methylation | LVKKLAKKYDAFLAS HHHHHHHHHHHHHHC | 42.63 | 23748837 | |
| 106 | Ubiquitination | LVKKLAKKYDAFLAS HHHHHHHHHHHHHHC | 42.63 | 21890473 | |
| 106 | Sumoylation | LVKKLAKKYDAFLAS HHHHHHHHHHHHHHC | 42.63 | 19608861 | |
| 106 | Acetylation | LVKKLAKKYDAFLAS HHHHHHHHHHHHHHC | 42.63 | 19608861 | |
| 106 | Malonylation | LVKKLAKKYDAFLAS HHHHHHHHHHHHHHC | 42.63 | 26320211 | |
| 107 | Phosphorylation | VKKLAKKYDAFLASE HHHHHHHHHHHHHCH | 16.28 | 28152594 | |
| 113 | Phosphorylation | KYDAFLASESLIKQI HHHHHHHCHHHHHHH | 29.84 | 28450419 | |
| 115 | Phosphorylation | DAFLASESLIKQIPR HHHHHCHHHHHHHHH | 32.66 | 28450419 | |
| 118 | Sumoylation | LASESLIKQIPRILG HHCHHHHHHHHHHHC | 47.68 | 19608861 | |
| 118 | Ubiquitination | LASESLIKQIPRILG HHCHHHHHHHHHHHC | 47.68 | 21890473 | |
| 118 | 2-Hydroxyisobutyrylation | LASESLIKQIPRILG HHCHHHHHHHHHHHC | 47.68 | - | |
| 118 | Acetylation | LASESLIKQIPRILG HHCHHHHHHHHHHHC | 47.68 | 19608861 | |
| 130 | Ubiquitination | ILGPGLNKAGKFPSL HHCCCCCCCCCCHHH | 64.66 | 21890473 | |
| 130 | Malonylation | ILGPGLNKAGKFPSL HHCCCCCCCCCCHHH | 64.66 | 26320211 | |
| 130 | Acetylation | ILGPGLNKAGKFPSL HHCCCCCCCCCCHHH | 64.66 | 25953088 | |
| 133 | Ubiquitination | PGLNKAGKFPSLLTH CCCCCCCCCHHHHCC | 59.99 | 21890473 | |
| 133 | Acetylation | PGLNKAGKFPSLLTH CCCCCCCCCHHHHCC | 59.99 | 23749302 | |
| 136 | Phosphorylation | NKAGKFPSLLTHNEN CCCCCCHHHHCCCCC | 38.86 | 30108239 | |
| 139 | Phosphorylation | GKFPSLLTHNENMVA CCCHHHHCCCCCCEE | 28.13 | 30108239 | |
| 144 | Sulfoxidation | LLTHNENMVAKVDEV HHCCCCCCEEEHHHH | 2.24 | 30846556 | |
| 147 | Ubiquitination | HNENMVAKVDEVKST CCCCCEEEHHHHHHH | 38.52 | - | |
| 147 | Acetylation | HNENMVAKVDEVKST CCCCCEEEHHHHHHH | 38.52 | 26051181 | |
| 147 | 2-Hydroxyisobutyrylation | HNENMVAKVDEVKST CCCCCEEEHHHHHHH | 38.52 | - | |
| 152 | 2-Hydroxyisobutyrylation | VAKVDEVKSTIKFQM EEEHHHHHHHHHHHH | 39.57 | - | |
| 152 | Ubiquitination | VAKVDEVKSTIKFQM EEEHHHHHHHHHHHH | 39.57 | - | |
| 152 | Succinylation | VAKVDEVKSTIKFQM EEEHHHHHHHHHHHH | 39.57 | 23954790 | |
| 152 | Acetylation | VAKVDEVKSTIKFQM EEEHHHHHHHHHHHH | 39.57 | 25953088 | |
| 156 | Ubiquitination | DEVKSTIKFQMKKVL HHHHHHHHHHHHHHH | 29.63 | - | |
| 156 | Acetylation | DEVKSTIKFQMKKVL HHHHHHHHHHHHHHH | 29.63 | 26051181 | |
| 161 | Sumoylation | TIKFQMKKVLCLAVA HHHHHHHHHHHHHHH | 34.79 | 28112733 | |
| 161 | Acetylation | TIKFQMKKVLCLAVA HHHHHHHHHHHHHHH | 34.79 | 26051181 | |
| 164 | S-palmitoylation | FQMKKVLCLAVAVGH HHHHHHHHHHHHHCC | 2.28 | 29575903 | |
| 174 | Sulfoxidation | VAVGHVKMTDDELVY HHHCCCCCCCCHHHH | 4.90 | 28183972 | |
| 192 | Phosphorylation | LAVNFLVSLLKKNWQ HHHHHHHHHHHHCCC | 30.08 | 24719451 | |
| 196 | Acetylation | FLVSLLKKNWQNVRA HHHHHHHHCCCHHHH | 64.49 | 26051181 | |
| 196 | Ubiquitination | FLVSLLKKNWQNVRA HHHHHHHHCCCHHHH | 64.49 | - | |
| 207 | 2-Hydroxyisobutyrylation | NVRALYIKSTMGKPQ HHHHHHHCCCCCCCC | 26.73 | - | |
| 207 | Acetylation | NVRALYIKSTMGKPQ HHHHHHHCCCCCCCC | 26.73 | 26051181 | |
| 207 | Ubiquitination | NVRALYIKSTMGKPQ HHHHHHHCCCCCCCC | 26.73 | - | |
| 212 | Ubiquitination | YIKSTMGKPQRLY-- HHCCCCCCCCCCC-- | 27.44 | 21890473 | |
| 215 | Methylation | STMGKPQRLY----- CCCCCCCCCC----- | 44.47 | 115491591 | |
| 217 | Phosphorylation | MGKPQRLY------- CCCCCCCC------- | 20.78 | 28102081 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL10A_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL10A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL10A_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-106 AND LYS-118, AND MASSSPECTROMETRY. | |